Viewing StudyNCT04565054



Ignite Creation Date: 2024-05-06 @ 3:13 PM
Last Modification Date: 2024-10-26 @ 1:45 PM
Study NCT ID: NCT04565054
Status: RECRUITING
Last Update Posted: 2024-03-01
First Post: 2020-07-07

Brief Title: Adjuvant Therapy With Abemaciclib SOC ET vs SOC ET in Clinical or Genomic High Risk HRHER2- EBC
Sponsor: West German Study Group
Organization: West German Study Group

Conditions & Keywords Data

Conditions:
Name
Breast Cancer Female
Keywords:
Name View
HR positive View
early breast cancer View
ADAPT View
endocrine therapy View
abemaciclib View
high risk View
HER2 negative View